Losses at SoftBank’s Vision Funds have consumed nearly all their historical gains

The Vision Fund was always a funded vision; today we learned just how cloudy that perspective is proving.

Roivant receives bad news — and so does SoftBank

Last month, SoftBank, through its massive Vision Fund, led the single biggest private financing round for a healthcare company ever -- funneling $1.1 billion into the drug holding outfit Roivant Sci

Roivant, which creates companies around abandoned drugs, just raised $1.1 billion from SoftBank

Roivant Sciences, a three-year-old, Basel, Switzerland-based company aiming to one day be a giant holding company for dozens of independent biopharmaceutical companies, has raised $1.1 billion in equi

The billion-dollar pharma startup that Silicon Valley has totally missed

If these black marks on the industry are slowing down 31-year-old Vivek Ramaswamy in any way, you wouldn’t know it. He thinks his company, Roivant, will one day be a giant holding company for dozens